Table 2 The results of path model A.

From: Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis

Clinical Factor

Estimate

Standard error

Test statistic

P-Value

Standard regression coefficient

Direct Effect

Indirect Effect

Total Effect

Vesssel Disease (R2 = 0.076)

Age

0.006

0.003

2.342

0.019

0.074

0

0.074

Gender

0.088

0.077

1.153

0.249

0.165

0

0.165

BMI

−0.014

0.007

−2.057

0.040

−0.058

0

−0.058

TG

−0.001

0.000

−2.319

0.020

−0.063

0

−0.063

Smoking

0.058

0.037

1.573

0.116

0.043

0

0.043

AO sys

0.004

0.001

3.502

<0.001

0.101

0

0.101

eGFR

−0.004

0.002

−2.725

0.006

−0.086

0

−0.086

HbA1c

0.161

0.026

6.142

<0.001

0.165

0

0.165

UA

0.055

0.020

2.792

0.005

0.080

0

0.080

LVEF (R2 = 0.146)

Age

0.176

0.032

5.500

<0.001

0.183

−0.016

0.166

Gender

0.088

0.885

−1.887

0.059

−0.055

−0.007

−0.062

BMI

−0.014

0.080

3.887

<0.001

0.114

0.013

0.127

TG

−0.001

0.003

2.502

0.012

0.071

0.014

0.085

Smoking

−0.810

0.429

−1.889

0.059

−0.054

−0.009

−0.063

AO sys

0.057

0.012

4.548

<0.001

0.131

−0.022

0.109

eGFR

0.107

0.018

5.935

<0.001

0.195

0.019

0.214

HbA1c

−1.056

0.305

−3.458

<0.001

−0.098

−0.036

−0.134

UA

−0.652

0.227

−2.868

0.004

−0.086

−0.018

−0.103

Vessel Disease

−2.417

0.306

−7.797

<0.001

−0.219.

0

−0.219

  1. The results (direct, indirect, and total effects) of the path model theoretically proposed analysis to identify the clinical factors influencing between each other (see Fig. 1). RMSEA 0.128, AIC 154.0.
  2. R2: squared multiple correlations.
  3. BMI, body mass index; TG, triglycerides; AO sys, Systolic blood pressure in the Aorta; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; UA, uric acid; LVEF, left ventricular ejection fraction.